TABLE 1. Self-reported demographic and baseline clinical characteristics of outpatients (N = 271) and inpatients (N = 79) with SARS-CoV-2 RT-PCR–positive test results at 14–21 days or 28–35 days after testing — academic medical centers,* United States, March–May 2020.
Characteristic | No. (%) |
|||
---|---|---|---|---|
Total (350) | Outpatients (271) | Inpatients (79) | P-value | |
Median age, yrs, (IQR)
|
43 (32–57)
|
42 (31–54) |
54 (36–68) |
<0.001 |
Female sex
|
185 (53)
|
144 (53) |
41 (52) |
0.85 |
Race/Ethnicity†
|
0.008 |
|||
White, non-Hispanic |
116 (33)
|
101 (37) |
15 (19) |
|
Black, non-Hispanic |
73 (21)
|
51 (19) |
22 (28) |
|
Hispanic |
116 (33)
|
82 (30) |
34 (43) |
|
Other, non-Hispanic |
43 (12)
|
35 (13) |
8 (10) |
|
Unknown |
2 (1)
|
2 (1) |
0 (0) |
|
Medical Insurance
|
0.85 |
|||
Yes |
289 (83)
|
222 (82) |
67 (85) |
|
No |
45 (13)
|
34 (13) |
11 (14) |
|
Unknown |
16 (5)
|
15 (6) |
1 (1) |
|
Education level
|
0.83 |
|||
Less than college |
177 (51)
|
135 (50) |
42 (53) |
|
Some college or more |
154 (44)
|
119 (44) |
35 (44) |
|
Unknown |
19 (5)
|
17 (6) |
2 (3) |
|
Annual household income
|
0.003 |
|||
<$25,000 |
56 (16)
|
34 (13) |
22 (28) |
|
$25,000–$49,000 |
92 (26)
|
77 (28) |
15 (19) |
|
$50,000–$74,000 |
33 (9)
|
27 (10) |
6 (8) |
|
>$74,000 |
57 (16)
|
49 (18) |
8 (10) |
|
Unknown/Refused to answer |
112 (32)
|
84 (31) |
28 (35) |
|
Underlying medical condition (334)§
| ||||
Number, median (IQR) |
1 (0–2)
|
1 (0–2) |
2 (1–3) |
<0.001 |
Any cardiac disease |
100 (30)
|
69 (27) |
31 (41) |
0.019 |
Hypertension |
97 (29)
|
67 (26) |
30 (39) |
0.023 |
Coronary artery disease |
10 (3)
|
5 (2) |
5 (7) |
0.037 |
Congestive heart failure |
9 (3)
|
3 (1) |
6 (8) |
0.005 |
Any respiratory disease |
65 (20)
|
40 (16) |
25 (33) |
0.001 |
Asthma |
55 (16)
|
36 (14) |
19 (25) |
0.022 |
COPD |
18 (5)
|
6 (2) |
12 (16) |
<0.001 |
Diabetes |
51 (15)
|
28 (11) |
23 (30) |
<0.001 |
Obesity (BMI ≥30 kg/m2) |
67 (20)
|
47 (18) |
20 (26) |
0.13 |
Chronic kidney disease |
14 (4)
|
8 (3) |
6 (8) |
0.067 |
Chronic liver disease |
11 (3)
|
5 (2) |
6 (8) |
0.011 |
Immunosuppressive condition |
22 (7)
|
16 (6) |
6 (8) |
0.60 |
Rheumatologic/Autoimmune condition |
28 (8)
|
20 (8) |
8 (11) |
0.45 |
Neurologic condition |
16 (5)
|
9 (4) |
7 (9) |
0.041 |
Blood disorder |
12 (4)
|
7 (3) |
5 (7) |
0.11 |
Psychiatric disorder |
69 (21)
|
52 (20) |
17 (23) |
0.65 |
Ever used tobacco¶
|
104 (31)
|
77 (30) |
27 (36) |
0.36 |
Current tobacco use (among ever users) |
17 (17)
|
15 (20) |
2 (7) |
0.23 |
Current alcohol use** | 112 (34) | 89 (35) | 23 (30) | 0.45 |
Abbreviations: BMI = body mass index; COPD = chronic obstructive pulmonary disease; IQR = interquartile range; RT-PCR = reverse transcription–polymerase chain reaction.
* Patients were sampled from 11 academic medical centers in nine states (University of Washington [Washington], Oregon Health and Sciences University [Oregon], University of California Los Angeles and Stanford University [California], Hennepin County Medical Center [Minnesota], Vanderbilt University [Tennessee], The Ohio State University [Ohio], Wake Forest University [North Carolina], Montefiore Medical Center [New York], Beth Israel Deaconess Medical Center and Baystate Medical Center [Massachusetts]).
† Other non-Hispanic included two persons who reported being American Indian/Alaska Native, 25 Asian, three Native Hawaiian/Other Pacific Islander, and 18 Other; five reported both Asian and Other for race. Other race group combined because of comparatively low numbers in these groups compared with other race/ethnicity groups.
§ Excluding 16 (5%) patients who did not answer questions about underlying medical conditions; for those who answered questions about underlying conditions, some respondents were missing data on congestive heart failure (one), obesity (three), rheumatologic/autoimmune conditions (one), neurologic conditions (one), and psychiatric conditions (two); denominators used to calculate proportions of respondents with individual underlying medical conditions excluded patients who have missing data for the condition.
¶ Unknown for 17 (14 outpatients and three inpatients); among those who had ever used tobacco products, one did not state whether they were a current tobacco user.
** Unknown for 19 (16 outpatients and three inpatients).